奥沙利铂在血液透析患者中的药代动力学：化疗剂量调整及透析时机 - Suppr

Pharmacokinetics of oxaliplatin in a hemodialyzed patient: chemotherapy dose adjustment and timing of dialysis.

作者信息

Gori Stefania, Lunardi Gianluigi, Inno Alessandro, Magarotto Roberto, Duranti Simona, Messa Michele Giuseppe, Mucchino Claudio, Cirillo Massimo

机构信息

Medical Oncology Department, Sacro Cuore Don Calabria Hospital, Negrar-Verona, Italy.

出版信息

Clin Colorectal Cancer. 2014 Dec;13(4):260-3. doi: 10.1016/j.clcc.2014.09.003. Epub 2014 Sep 21.

DOI:10.1016/j.clcc.2014.09.003

PMID:25314931

Abstract

摘要

相似文献

Pharmacokinetics of oxaliplatin in a hemodialyzed patient: chemotherapy dose adjustment and timing of dialysis.奥沙利铂在血液透析患者中的药代动力学：化疗剂量调整及透析时机

Clin Colorectal Cancer. 2014 Dec;13(4):260-3. doi: 10.1016/j.clcc.2014.09.003. Epub 2014 Sep 21.

Clinical pharmacokinetics of oxaliplatin and 5-fluorouracil administered in combination with leucovorin in Korean patients with advanced colorectal cancer.奥沙利铂和5-氟尿嘧啶联合亚叶酸钙用于韩国晚期结直肠癌患者的临床药代动力学

J Cancer Res Clin Oncol. 2006 May;132(5):320-6. doi: 10.1007/s00432-005-0072-6. Epub 2006 Jan 4.

A phase I, pharmacokinetic and pharmacodynamic study on vorinostat in combination with 5-fluorouracil, leucovorin, and oxaliplatin in patients with refractory colorectal cancer.一项关于伏立诺他联合5-氟尿嘧啶、亚叶酸钙和奥沙利铂治疗难治性结直肠癌患者的I期药代动力学和药效学研究。

Clin Cancer Res. 2009 May 1;15(9):3189-95. doi: 10.1158/1078-0432.CCR-08-2999. Epub 2009 Apr 21.

Oxaliplatin-induced immune hemolytic anemia: a case report and review of the literature.奥沙利铂诱导的免疫性溶血性贫血：一例报告及文献复习

Anticancer Drugs. 2007 Sep;18(8):973-6. doi: 10.1097/CAD.0b013e3280e9496d.

Gene expression signature and response to the use of leucovorin, fluorouracil and oxaliplatin in colorectal cancer patients.结直肠癌患者中白细胞生成素、氟尿嘧啶和奥沙利铂使用的基因表达特征和反应。

Clin Transl Oncol. 2011 Jun;13(6):419-25. doi: 10.1007/s12094-011-0676-z.

Response to chemotherapy in metastatic colorectal cancer after exposure to oxaliplatin in the adjuvant setting.辅助治疗中使用奥沙利铂后转移性结直肠癌患者的化疗反应。

Anticancer Res. 2013 Apr;33(4):1765-8.

Pharmacokinetics of oxaliplatin in a hemodialytic patient treated with modified FOLFOX-6 plus bevacizumab therapy.奥沙利铂在接受改良 FOLFOX-6 联合贝伐珠单抗治疗的血液透析患者中的药代动力学。

Cancer Chemother Pharmacol. 2011 Jul;68(1):263-6. doi: 10.1007/s00280-011-1633-9. Epub 2011 Apr 16.

Administration of reduced glutathione in FOLFOX4 adjuvant treatment for colorectal cancer: effect on oxaliplatin pharmacokinetics, Pt-DNA adduct formation, and neurotoxicity.还原型谷胱甘肽在FOLFOX4辅助治疗结直肠癌中的应用：对奥沙利铂药代动力学、铂-DNA加合物形成及神经毒性的影响

Anticancer Drugs. 2009 Jun;20(5):396-402. doi: 10.1097/CAD.0b013e32832a2dc1.

[FOLFOX 4 in a patient with metastatic colorectal cancer on hemodialysis due to chronic renal failure].[因慢性肾衰竭接受血液透析的转移性结直肠癌患者应用FOLFOX 4方案]

Gan To Kagaku Ryoho. 2007 Aug;34(8):1299-302.

Phase II study of gefitinib, fluorouracil, leucovorin, and oxaliplatin therapy in previously treated patients with metastatic colorectal cancer.吉非替尼、氟尿嘧啶、亚叶酸钙和奥沙利铂治疗既往治疗过的转移性结直肠癌患者的II期研究。

J Clin Oncol. 2005 Aug 20;23(24):5613-9. doi: 10.1200/JCO.2005.08.359.

引用本文的文献

Management of cytotoxic chemotherapy in patients undergoing dialysis: a still unresolved issue of onconephrology.透析患者细胞毒性化疗的管理：肿瘤肾脏病学中一个仍未解决的问题。

J Nephrol. 2024 Oct 15. doi: 10.1007/s40620-024-02102-7.

Systemic Treatment for Gynecological Cancer Patients Undergoing Hemodialysis.接受血液透析的妇科癌症患者的全身治疗。

Onco Targets Ther. 2023 Jul 8;16:545-558. doi: 10.2147/OTT.S419445. eCollection 2023.

Chemotherapy for non-Hodgkin lymphoma in the hemodialysis patient: A comprehensive review.血液透析患者非霍奇金淋巴瘤的化疗：全面综述。

Cancer Sci. 2021 Jul;112(7):2607-2624. doi: 10.1111/cas.14933. Epub 2021 Jun 11.

High-throughput three-dimensional spheroid tumor model using a novel stamp-like tool.使用新型印章状工具的高通量三维球体肿瘤模型。

J Tissue Eng. 2019 Nov 29;10:2041731419889184. doi: 10.1177/2041731419889184. eCollection 2019 Jan-Dec.

Dose-escalation of oxaliplatin in hemodialysis patient treated with FOLFOX therapy: A case report.接受FOLFOX方案治疗的血液透析患者中奥沙利铂的剂量递增：一例报告

Medicine (Baltimore). 2019 Nov;98(44):e17462. doi: 10.1097/MD.0000000000017462.

Modified FOLFOX-6 Plus Bevacizumab Chemotherapy for Metastatic Colorectal Cancer in Patients Receiving Hemodialysis: A Report of Three Cases and Review of the Literature.改良FOLFOX-6方案联合贝伐单抗化疗用于接受血液透析的转移性结直肠癌患者：三例报告及文献复习

Case Rep Oncol. 2019 Aug 16;12(2):657-665. doi: 10.1159/000502512. eCollection 2019 May-Aug.

Treatment of Gastric and Gastroesophageal Cancer Patients with Hemodialysis by CapeOX.用 CapeOX 方案治疗接受血液透析的胃癌和胃食管癌患者。

Intern Med. 2019 Oct 1;58(19):2791-2795. doi: 10.2169/internalmedicine.2718-19. Epub 2019 Jun 27.

Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan.接受血液透析的癌症患者的化疗：日本的一项全国性研究。

ESMO Open. 2018 Feb 23;3(2):e000301. doi: 10.1136/esmoopen-2017-000301. eCollection 2018.

Management of patients with end-stage renal disease undergoing chemotherapy: recommendations of the Associazione Italiana di Oncologia Medica (AIOM) and the Società Italiana di Nefrologia (SIN).终末期肾病患者化疗管理：意大利医学肿瘤学会（AIOM）和意大利肾脏病学会（SIN）的建议

ESMO Open. 2017 Jul 19;2(3):e000167. doi: 10.1136/esmoopen-2017-000167. eCollection 2017.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pharmacokinetics of oxaliplatin in a hemodialyzed patient: chemotherapy dose adjustment and timing of dialysis.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献